Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (371-380 of 384) with videos related to

Pageof 39
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study GroupG Rezza, A C Lepri, A d'Arminio Monforte, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.
ESMO Open|July 6, 2024
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agentsC Casartelli, C Tommasi, A Lazzarin, et al.
The Journal of Frailty & Aging|February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected PersonsG Guaraldi, S Marcotullio, R Maserati, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for AntiretroviralsM Violin, F Forbici, A Cozzi-Lepri, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Reviews on Recent Clinical Trials|December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidateS Bellino, V Francavilla, O Longo, et al.
Infection|May 30, 2009
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapyA Antinori, A Ammassari, C Torti, et al.
Pageof 39

Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study GroupG Rezza, A C Lepri, A d'Arminio Monforte, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.
ESMO Open|July 6, 2024
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agentsC Casartelli, C Tommasi, A Lazzarin, et al.
The Journal of Frailty & Aging|February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected PersonsG Guaraldi, S Marcotullio, R Maserati, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for AntiretroviralsM Violin, F Forbici, A Cozzi-Lepri, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Reviews on Recent Clinical Trials|December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidateS Bellino, V Francavilla, O Longo, et al.
Infection|May 30, 2009
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapyA Antinori, A Ammassari, C Torti, et al.
Pageof 39